RLAY
Relay Therapeutics Inc.
$6.03
-$0.24(-3.83%)
59
Overall
60
Value
75
Tech
42
Quality
Market Cap
$803.44M
Volume
1.57M
52W Range
$1.78 - $7.07
Target Price
$13.60
EPS Estimates Overview
| Current Quarter | $-0.39 | Next Quarter | $-0.3 |
| Current Year | $-1.59 | Next Year | $-1.52 |
| QoQ Growth | +23.1% | YoY Growth | +4.4% |
| 3Y EPS CAGR | +14.8% | Target Price | $13.60 |
| Consensus | Buy | Upside | +125.5% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | RLAY | $6.03 | -3.8% | 1.57M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |